$0.000001
At close: Mar 6, 2:47 PM EDT
Comments
Loading...
Poniard Pharmaceuticals Stock Guidance | OTC:PARD | Benzinga
Poniard Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Poniard Pharmaceuticals (PARD)?
There have been no specific sales or earnings guidance reported for Poniard Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.